TruScreen is a breakthrough product in cervical screening, providing real-time reporting without the need for laboratory testing and offering women a more accessible screening process that minimises personal discomfort.
Learn more about this exciting new technology that will improve the health outcomes of women around the world.
TruScreen is a new technology used to detect pre-cancerous change, or cervical intraepithelial neoplasia (CIN), by optical and electrical measurements of cervical tissue.
TruScreen offers a new approach to cervical screening, resolving many of the ongoing issues with Pap tests including failed samples and poor patient follow up.
Pioneering research and development on the TruScreen system for real-time cervical tissue differentiation has involved close collaboration with leading clinicians and hospitals across the world.
TruScreen has been extensively tested in numerous studies around the world, with results showing its performance is equal to, or better than, high quality cytology…
Learn more about the TruScreen system to fully understand its capabilities and potential.